Clinical Neurology NewsTop Acthar prescribers reap hefty payments from drug makerMay 3, 2017Multiple Sclerosis
Clinical Neurology NewsKids with MS face higher risk of mental disordersApril 26, 2017Multiple SclerosisPediatrics
Clinical Neurology NewsEvidence for medical marijuana largely up in smokeApril 7, 2017PainMultiple SclerosisBusiness of Medicine
Neurology ReviewsDisease-Modifying Treatment Changes in Clinical PracticeMarch 29, 2017Multiple Sclerosis
Neurology ReviewsCan Gene Expression–Based Technologies Help Diagnose MS?March 29, 2017Multiple Sclerosis
Clinical Neurology NewsOcrelizumab gets first-ever FDA approval for primary progressive MSMarch 29, 2017Multiple Sclerosis
Neurology ReviewsMS May Reduce Life Expectancy and Increase MortalityMarch 28, 2017Multiple Sclerosis
Neurology ReviewsWhat Is the Impact of a High-Salt Diet in Patients With MS?March 28, 2017Multiple Sclerosis
Neurology ReviewsEarly Interferon Treatment Delays Time to Clinically Definite MSMarch 6, 2017Multiple Sclerosis
